- Home
- PTGX vs ASPN Comparison
PTGX vs ASPN Comparison
Compare PTGX & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- ASPN
- Stock Information
- Founded
- PTGX 2006
- ASPN 2001
- Country
- PTGX United States
- ASPN United States
- Employees
- PTGX N/A
- ASPN N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- PTGX Health Care
- ASPN Consumer Discretionary
- Exchange
- PTGX Nasdaq
- ASPN Nasdaq
- Market Cap
- PTGX 2.8B
- ASPN 1.5B
- IPO Year
- PTGX 2016
- ASPN 2014
- Fundamental
- Price
- PTGX $47.91
- ASPN $18.31
- Analyst Decision
- PTGX Strong Buy
- ASPN Strong Buy
- Analyst Count
- PTGX 7
- ASPN 9
- Target Price
- PTGX $52.83
- ASPN $32.00
- AVG Volume (30 Days)
- PTGX 450.1K
- ASPN 3.0M
- Earning Date
- PTGX 11-08-2024
- ASPN 11-06-2024
- Dividend Yield
- PTGX N/A
- ASPN N/A
- EPS Growth
- PTGX N/A
- ASPN N/A
- EPS
- PTGX 2.75
- ASPN 0.02
- Revenue
- PTGX $319,120,000.00
- ASPN $357,245,000.00
- Revenue This Year
- PTGX $400.33
- ASPN $72.06
- Revenue Next Year
- PTGX N/A
- ASPN $30.15
- P/E Ratio
- PTGX $17.54
- ASPN $954.90
- Revenue Growth
- PTGX 125.73
- ASPN 87.96
- 52 Week Low
- PTGX $13.76
- ASPN $7.37
- 52 Week High
- PTGX $48.89
- ASPN $33.15
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- ASPN 32.60
- Support Level
- PTGX $45.33
- ASPN $18.95
- Resistance Level
- PTGX $48.89
- ASPN $20.19
- Average True Range (ATR)
- PTGX 1.28
- ASPN 1.47
- MACD
- PTGX 0.11
- ASPN -0.39
- Stochastic Oscillator
- PTGX 77.11
- ASPN 3.31
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.